# CORT PDUFA Calendar: FDA Decision Dates & Catalyst Timeline

Canonical URL: https://biopharmsignal.com/pdufa-calendar/CORT
Company: Corcept

BioPharmSignal tracks active PDUFA and FDA decision milestones associated with CORT.

## CORT PDUFA Milestones

- 2025-12-30 — CRL — FDA issued Complete Response Letter. The sponsor reported that FDA issued a Complete Response Letter for Relacorilant on December 30, 2025. This list-only hi...
  Company: Corcept
  Source: https://www.sec.gov/Archives/edgar/data/1088856/000119312525338184/d50993dex991.htm
  Event detail: https://biopharmsignal.com/pdufa-calendar/CORT/relacorilant-relacorilant-hypercortisolism-nda.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/december (December 2025)
- 2026-03-25 — FDA Approval — FDA approved application. FDA recorded approval of LIFYORLI (COPACKAGED) on March 25, 2026. This list-only historical record is sourced from the official FDA...
  Company: Corcept
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220641
  Event detail: https://biopharmsignal.com/pdufa-calendar/CORT/lifyorli-copackaged-nda-220641-orig-1.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/march (March 2026)
- 2026-07-11 — PDUFA — FDA approved LIFYORLI plus nab-paclitaxel. FDA approved LIFYORLI with nab-paclitaxel for eligible adults with platinum-resistant epithelial ovarian, fallopia...
  Company: Corcept
  Source: https://ir.corcept.com/news-releases/news-release-details/fda-approves-corcepts-selective-glucocorticoid-receptor
  Event detail: https://biopharmsignal.com/pdufa-calendar/CORT/relacorilant-platinum-resistant-ovarian-cancer.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/july (July 2026)

## Related Pages

- Company page: https://biopharmsignal.com/company/CORT
- Interactive PDUFA Calendar: https://biopharmsignal.com/pdufa-calendar

## FAQ

### What does the CORT PDUFA calendar show?

It shows active PDUFA and FDA decision milestones associated with CORT, including decision dates, application stage, and summary details when available.
### Where can I find more context for CORT?

Use the BioPharmSignal company page for CORT to read related news, stock data, sector context, and company-specific updates.
### Are these dates investment advice?

No. PDUFA dates are research inputs, not investment recommendations. Always review primary sources and understand the clinical and regulatory context.